First Trust Nyse Arca Biotech Etf logo

First Trust Nyse Arca Biotech Etf (FBT) Technical Analysis

$187.72-1%

Market is closed - opens 7 PM, 23 Oct 2025

Insights

  • First Trust Nyse Arca Biotech Etf is currently in a neutral trading position according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for First Trust Nyse Arca Biotech Etf stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, First Trust Nyse Arca Biotech Etf stock is in a uptrend ↗️
  • Based on analysis of the Pivot Points, the current market trend for First Trust Nyse Arca Biotech Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
65.45
Sell
Stochastic
90.13, 87.08
Neutral
Ultimate Oscillator
50.08
Neutral
Stochastic Relative Strength Index
62.94, 57.29
Neutral
Moving Average Convergence Divergence
3.06, 2.97
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
186.64
Buy
20
184.32
Buy
50
178.65
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
187.02
Buy
20
184.76
Buy
50
179.28
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
186.75
Neutral
20
184.55
Neutral
50
178.82
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
189.11
Buy
20
188.89
Buy
50
186.52
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
189.19
Sell
20
189.26
Buy
50
189.1
Buy

Pivot

Pivot

Value

Resistance L3
193.07
Resistance L2
191.75
Resistance L1
190.57
Pivot Point
189.25
Support L1
188.07
Support L2
186.75
Support L3
185.57

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.